{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:17:52Z","timestamp":1794367072267,"version":"4.9.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.lanepe.2025.101501","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:34:54Z","timestamp":1760808894000},"page":"101501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Longitudinal data on advanced cutaneous squamous cell carcinoma from the Dutch Keratinocyte Cancer Collaborative (DKCC): a nationwide real-world database study"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8922-6791","authenticated-orcid":false,"given":"Loes M.","family":"Hollestein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste J.","family":"Eggermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke W.J.","family":"Louwman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Schreuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meggie C.M.","family":"Drissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9183-9287","authenticated-orcid":false,"given":"Olivia F.M.","family":"Steijlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9810-5780","authenticated-orcid":false,"given":"Antien L.","family":"Mooyaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette H.","family":"Bruggink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2631-7976","authenticated-orcid":false,"given":"Quirinus J.M.","family":"Voorham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Grunhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Jalving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar E.C.","family":"Nijsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8578-901X","authenticated-orcid":false,"given":"Marlies","family":"Wakkee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2025.101501_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jdin.2020.10.013","article-title":"The global burden of skin cancer: a longitudinal analysis from the Global Burden of Disease Study, 1990-2017","volume":"2","author":"Urban","year":"2021","journal-title":"JAAD Int"},{"issue":"6","key":"10.1016\/j.lanepe.2025.101501_bib2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101501_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamadermatol.2018.4219","article-title":"Nationwide incidence of metastatic cutaneous squamous cell carcinoma in England","volume":"155","author":"Venables","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.lanepe.2025.101501_bib4","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.jid.2017.06.025","article-title":"Survival of patients with cutaneous squamous cell carcinoma: results of a prospective cohort study","volume":"137","author":"Eigentler","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101501_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaad.2021.09.067","article-title":"Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma: a nationwide cancer registry study","volume":"86","author":"Tokez","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101501_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/bjd.19879","article-title":"Invasive and in situ squamous cell carcinoma of the skin: a nationwide study in Iceland","volume":"185","author":"Adalsteinsson","year":"2021","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101501_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.17873","article-title":"Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study","volume":"181","author":"Venables","year":"2019","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.lanepe.2025.101501_bib8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/bjd\/ljad425","article-title":"International patterns and trends in the incidence of melanoma and cutaneous squamous cell carcinoma, 1989-2020","volume":"190","author":"Olsen","year":"2024","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.lanepe.2025.101501_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jid.2022.07.008","article-title":"Development and validation of an algorithm to identify patients with advanced cutaneous squamous cell carcinoma from pathology reports","volume":"143","author":"Eggermont","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.lanepe.2025.101501_bib10","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jamadermatol.2020.3677","article-title":"Incidence of multiple vs first cutaneous squamous cell carcinoma on a nationwide scale and estimation of future incidences of cutaneous squamous cell carcinoma","volume":"156","author":"Tokez","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.lanepe.2025.101501_bib11","first-page":"19","article-title":"Pathology databanking and biobanking in the Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Cell Oncol"},{"issue":"4","key":"10.1016\/j.lanepe.2025.101501_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101501_bib13","first-page":"122","article-title":"Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual","volume":"67","author":"Lydiatt","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.lanepe.2025.101501_bib14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.lanepe.2025.101501_bib15","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1245\/s10434-012-2504-2","article-title":"Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal staging system for metastatic cutaneous squamous cell carcinoma of the head and neck","volume":"19","author":"Clark","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.lanepe.2025.101501_bib16","series-title":"International classification of diseases for oncology","author":"Fritz","year":"2000"},{"issue":"8","key":"10.1016\/j.lanepe.2025.101501_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/14737167.2023.2223982","article-title":"Real-world analysis of cost, treatment patterns, and outcomes of patients with metastatic cutaneous squamous cell carcinoma in the US","volume":"23","author":"Song","year":"2023","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"22","key":"10.1016\/j.lanepe.2025.101501_bib18","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.3390\/cancers14225543","article-title":"Response to first-line treatment with immune-checkpoint inhibitors in patients with advanced cutaneous squamous cell carcinoma: a multicenter, retrospective analysis from the German ADOReg registry","volume":"14","author":"Haist","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lanepe.2025.101501_bib19","volume":"Vol. 3","author":"Weichenthal","year":"2025"},{"issue":"5","key":"10.1016\/j.lanepe.2025.101501_bib20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjd.20909","article-title":"Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data","volume":"186","author":"Venables","year":"2022","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.lanepe.2025.101501_bib21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1056\/NEJMoa2502449","article-title":"Adjuvant cemiplimab or placebo in high-risk cutaneous squamous-cell carcinoma","volume":"393","author":"Rischin","year":"2025","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.lanepe.2025.101501_bib22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/DSS.0000000000003606","article-title":"Rate and characteristics of incompletely excised cutaneous squamous cell carcinoma: a dermatological daily practice multicenter prospective cohort study","volume":"48","author":"van Lee","year":"2022","journal-title":"Dermatol Surg"},{"issue":"10","key":"10.1016\/j.lanepe.2025.101501_bib23","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.jid.2020.01.035","article-title":"Prognostic impact of perineural invasion in cutaneous squamous cell carcinoma: results of a prospective study of 1,399 tumors","volume":"140","author":"Haug","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.lanepe.2025.101501_bib24","doi-asserted-by":"crossref","first-page":"e1136","DOI":"10.1111\/jdv.19150","article-title":"The impact of routine ultrasonography on nodal metastasis in head and neck cutaneous squamous cell carcinoma: a retrospective multicentre cohort study","volume":"37","author":"Eggermont","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.lanepe.2025.101501_bib25","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jaad.2023.08.012","article-title":"Transcriptomic analysis of cutaneous squamous cell carcinoma reveals a multigene prognostic signature associated with metastasis","volume":"89","author":"Wang","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lanepe.2025.101501_bib26","doi-asserted-by":"crossref","first-page":"102150","DOI":"10.1016\/j.eclinm.2023.102150","article-title":"Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model","volume":"63","author":"Rentroia-Pacheco","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.lanepe.2025.101501_bib27","doi-asserted-by":"crossref","first-page":"100875","DOI":"10.1016\/j.lanepe.2024.100875","article-title":"Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG access protocol","volume":"39","author":"Verkerk","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"17","key":"10.1016\/j.lanepe.2025.101501_bib28","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa2209813","article-title":"Neoadjuvant cemiplimab for stage II to IV cutaneous squamous-cell carcinoma","volume":"387","author":"Gross","year":"2022","journal-title":"N Engl J Med"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776225002935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776225002935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:57:46Z","timestamp":1773363466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776225002935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S2666776225002935"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101501","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal data on advanced cutaneous squamous cell carcinoma from the Dutch Keratinocyte Cancer Collaborative (DKCC): a nationwide real-world database study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101501"}}